Hay, K. A., Gauthier, J., Hirayama, A. V., Voutsinas, J. M., Wu, Q., Li, D., . . . Turtle, C. J. (2019). Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy. Blood, 133(15), 1652. https://doi.org/10.1182/blood-2018-11-883710
Chicago-Zitierstil (17. Ausg.)Hay, Kevin A., et al. "Factors Associated with Durable EFS in Adult B-cell ALL Patients Achieving MRD-negative CR After CD19 CAR T-cell Therapy." Blood 133, no. 15 (2019): 1652. https://doi.org/10.1182/blood-2018-11-883710.
MLA-Zitierstil (9. Ausg.)Hay, Kevin A., et al. "Factors Associated with Durable EFS in Adult B-cell ALL Patients Achieving MRD-negative CR After CD19 CAR T-cell Therapy." Blood, vol. 133, no. 15, 2019, p. 1652, https://doi.org/10.1182/blood-2018-11-883710.